David Aronoff

Aronoff David 250

Dr. Aronoff is an infectious diseases physician-scientist with an interest in defining host and microbial determinants of disease pathogenesis. His research primarily centers on the role of innate immunity in defending against gram positive bacteria such as streptococci and clostridia. Research on toxigenic clostridia by the Aronoff lab has revealed important mechanisms relevant to postpartum toxic shock syndrome caused by Clostridium sordellii and antibiotic-induced colitis caused by C. difficile. Currently, the Aronoff lab is devoted to defining why and how women develop intrauterine bacterial infections during pregnancy (chorioamnionitis), which frequently lead to preterm labor, stillbirth, or neonatal sepsis. Dr. Aronoff also leads the Vanderbilt Pre3 Initiative (Preventing adverse Pregnancy outcomes & Prematurity), a transdisciplinary program aimed at improving maternal-child health through discovery, innovation, education, and implementation.

See: https://tinyurl.com/ox8bxyg

 

TPL_asm2013_ADDITIONAL_INFORMATION

TPL_asm2013_SEARCH

6525:david-aronoff